Astrana Health, Inc. - Common Stock (ASTH) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2017 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ASTH on Nasdaq
Shares outstanding
49,931,653
Price per share
$24.81
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
26,741,871
Total reported value
$759,044,686
% of total 13F portfolios
0%
Share change
+666,882
Value change
+$21,223,463
Number of holders
185
Price from insider filings
$24.81
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Astrana Health, Inc. - Common Stock (ASTH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% +9.1% $191,646,870 -$6,109,882 6,234,446 -3.1% BlackRock, Inc. 31 Mar 2025
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp 11% -10% $188,522,333 -$21,514,803 6,132,802 -10% Allied Physicians of California, a Professional Medical Corporation 15 Feb 2025
VANGUARD GROUP INC 9.7% $120,258,461 4,833,384 The Vanguard Group 30 Jun 2025

As of 30 Sep 2025, 185 institutional investors reported holding 26,741,871 shares of Astrana Health, Inc. - Common Stock (ASTH). This represents 54% of the company’s total 49,931,653 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Astrana Health, Inc. - Common Stock (ASTH) together control 46% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 6,007,634 +0.2% 0% $170,316,424
VANGUARD GROUP INC 9.5% 4,721,076 -2.3% 0% $133,842,504
STATE STREET CORP 3.2% 1,577,452 -1.5% 0% $44,720,764
DIMENSIONAL FUND ADVISORS LP 2.5% 1,234,721 -2.2% 0.01% $35,006,710
325 CAPITAL LLC 2.4% 1,193,953 +35% 10% $33,848,568
FMR LLC 2.2% 1,075,723 -9.6% 0% $30,496,737
GEODE CAPITAL MANAGEMENT, LLC 2% 1,015,956 -3.5% 0% $28,806,657
SteelPeak Wealth, LLC 1.2% 579,937 +7.8% 0.55% $16,441,214
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.1% 562,314 +12% 0% $15,941,602
JACOBS LEVY EQUITY MANAGEMENT, INC 1% 500,527 +19% 0.06% $14,189,940
MORGAN STANLEY 1% 497,867 -2.1% 0% $14,114,552
NorthCrest Asset Manangement, LLC 0.9% 448,381 -0.12% 0.32% $13,599,396
AMERIPRISE FINANCIAL INC 0.89% 442,314 +231% 0% $12,539,603
NORTHERN TRUST CORP 0.85% 423,249 -2.6% 0% $11,999,108
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.84% 421,710 +44% 0.04% $11,955,479
DIAMOND HILL CAPITAL MANAGEMENT INC 0.72% 361,264 +33% 0.05% $10,241,834
GOLDMAN SACHS GROUP INC 0.63% 316,996 +61% 0% $8,986,836
ROYCE & ASSOCIATES LP 0.52% 259,353 -16% 0.07% $7,352,658
Bank of New York Mellon Corp 0.49% 245,271 -2.6% 0% $6,953,441
Invesco Ltd. 0.49% 243,236 +1.3% 0% $6,895,740
PRINCIPAL FINANCIAL GROUP INC 0.45% 222,985 +0.27% 0% $6,321,624
AXA Investment Managers S.A. 0.42% 207,479 0% 0.02% $5,882,030
Pacer Advisors, Inc. 0.36% 181,910 0.01% $5,157,149
LPL Financial LLC 0.36% 178,034 0% $5,047,264
BANK OF AMERICA CORP /DE/ 0.35% 172,855 +100% 0% $4,900,439

Institutional Holders of Astrana Health, Inc. - Common Stock (ASTH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,338,818 $34,665,580 +$3,307,877 $24.81 19
2025 Q3 26,741,871 $759,044,686 +$21,223,463 $28.35 185
2025 Q2 25,772,189 $641,392,329 -$15,342,979 $24.88 161
2025 Q1 26,257,633 $814,637,036 +$5,862,823 $31.01 168
2024 Q4 26,057,927 $822,017,819 +$3,128,832 $31.53 177
2024 Q3 25,295,709 $1,465,673,353 +$131,700,353 $57.94 186
2024 Q2 23,072,576 $935,815,210 +$22,763,995 $40.56 169
2024 Q1 22,756,494 $955,393,465 +$24,413,741 $41.99 158
2023 Q4 22,178,838 $849,210,903 +$26,256,665 $38.30 141
2023 Q3 21,503,159 $663,623,547 +$22,662,738 $30.85 132
2023 Q2 20,757,071 $656,229,537 +$22,212,849 $31.60 129
2023 Q1 20,034,782 $730,631,066 +$14,461,853 $36.47 131
2022 Q4 19,704,382 $583,144,207 -$13,404,604 $29.59 129
2022 Q3 19,814,272 $772,607,625 +$70,014,740 $39.00 148
2022 Q2 17,767,757 $685,808,256 +$18,274,263 $38.59 126
2022 Q1 17,609,470 $853,298,644 +$10,418,988 $48.47 129
2021 Q4 17,108,614 $1,256,730,970 +$26,349,379 $73.48 140
2021 Q3 16,644,270 $1,516,521,911 +$595,571,146 $91.05 137
2021 Q2 10,256,705 $644,299,364 +$260,959,544 $62.81 102
2021 Q1 6,359,542 $172,275,211 +$32,027,527 $27.09 75
2020 Q4 5,211,206 $95,222,607 +$2,906,278 $18.27 60
2020 Q3 5,058,422 $90,682,749 +$15,496,005 $17.94 62
2020 Q2 4,195,952 $69,229,389 +$12,105,432 $16.50 49
2020 Q1 3,507,141 $45,315,795 -$1,124,491 $12.92 49
2019 Q4 3,560,356 $65,544,872 -$36,902,879 $18.41 54
2019 Q3 5,569,591 $98,135,067 +$47,954,977 $17.62 46
2019 Q2 2,846,110 $47,557,190 +$8,339,757 $16.71 36
2019 Q1 2,387,347 $43,737,062 -$549,177 $18.33 37
2018 Q4 2,407,330 $47,779,685 +$851,599 $19.85 39
2018 Q3 2,283,686 $50,402,877 -$7,479,217 $22.07 36
2018 Q2 2,611,128 $67,524,947 +$58,395,475 $25.86 32
2018 Q1 541,971 $8,644,000 +$7,424,160 $15.95 13
2017 Q4 50,403 $1,209,000 +$1,209,000 $23.97 6